Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

Dennis E Doherty1, Donald P Tashkin2, Edward Kerwin3, Barbara A Knorr4, Tulin Shekar4, Sibabrata Banerjee4, Heribert Staudinger41Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky, Lexington, KY, 2David Geffen School of Medicine at UCLA, Los Angeles, CA, 3Clinical Resea...

Full description

Bibliographic Details
Main Authors: Doherty DE, Tashkin DP, Kerwin E, Knorr BA, Shekar T, Banerjee S, Staudinger H
Format: Article
Language:English
Published: Dove Medical Press 2012-02-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/effects-of-mometasone-furoateformoterol-fumarate-fixed-dose-combinatio-a9202

Internet

http://www.dovepress.com/effects-of-mometasone-furoateformoterol-fumarate-fixed-dose-combinatio-a9202

Similar Items